• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高影响力:别构结合位点在多靶标药物化学中的作用。

High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.

机构信息

Université de Paris, Biologie Fonctionnelle et Adaptative, UMR 8251, CNRS, ERL U1133, INSERM, Computational Modeling of Protein Ligand Interactions, F-75013 Paris, France.

Centre de Recherche des Cordeliers, Sorbonne Universités, INSERM, USPC, Université Paris Descartes, Université Paris Diderot, Université Paris 13, Functional Genomics of Solid Tumors Laboratory, F-75006 Paris, France.

出版信息

Molecules. 2019 Jul 10;24(14):2529. doi: 10.3390/molecules24142529.

DOI:10.3390/molecules24142529
PMID:31295958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6680532/
Abstract

The literature focuses on drug promiscuity, which is a drug's ability to bind to several targets, because it plays an essential role in polypharmacology. However, little work has been completed regarding binding site promiscuity, even though its properties are now recognized among the key factors that impact drug promiscuity. Here, we quantified and characterized the promiscuity of druggable binding sites from protein-ligand complexes in the high quality Mother Of All Databases while using statistical methods. Most of the sites (80%) exhibited promiscuity, irrespective of the protein class. Nearly half were highly promiscuous and able to interact with various types of ligands. The corresponding pockets were rather large and hydrophobic, with high sulfur atom and aliphatic residue frequencies, but few side chain atoms. Consequently, their interacting ligands can be large, rigid, and weakly hydrophilic. The selective sites that interacted with one ligand type presented less favorable pocket properties for establishing ligand contacts. Thus, their ligands were highly adaptable, small, and hydrophilic. In the dataset, the promiscuity of the site rather than the drug mainly explains the multiple interactions between the drug and target, as most ligand types are dedicated to one site. This underlines the essential contribution of binding site promiscuity to drug promiscuity between different protein classes.

摘要

文献主要关注药物混杂性,即药物与多个靶点结合的能力,因为它在多药理学中起着至关重要的作用。然而,尽管现在已经认识到结合位点混杂性是影响药物混杂性的关键因素之一,但针对其特性的研究却很少。在这里,我们使用统计方法对高质量的“所有数据库之母”中的蛋白质-配体复合物中的可成药性结合位点的混杂性进行了量化和特征描述。大多数(80%)位点表现出混杂性,与蛋白质类别无关。近一半的位点具有高度混杂性,能够与各种类型的配体相互作用。相应的口袋较大且疏水性强,硫原子和脂肪族残基频率较高,但侧链原子较少。因此,它们相互作用的配体可以较大、刚性且弱亲水性。与一种配体类型相互作用的选择性位点,其口袋性质不利于建立配体接触。因此,它们的配体具有高度适应性、较小和较强的亲水性。在数据集内,与靶标相互作用的配体类型较少,而不是药物的混杂性主要解释了药物与靶标之间的多种相互作用,因为大多数配体类型都专门针对一个位点。这突显了结合位点混杂性对不同蛋白质类别之间药物混杂性的重要贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/5b46aa189546/molecules-24-02529-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/c1f95e5456d3/molecules-24-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/600cefdca307/molecules-24-02529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/582c13f64eb9/molecules-24-02529-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/09c1b9bc41e4/molecules-24-02529-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/5c5a9e428359/molecules-24-02529-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/e5a53158948f/molecules-24-02529-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/eb4750d7356b/molecules-24-02529-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/5b46aa189546/molecules-24-02529-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/c1f95e5456d3/molecules-24-02529-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/600cefdca307/molecules-24-02529-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/582c13f64eb9/molecules-24-02529-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/09c1b9bc41e4/molecules-24-02529-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/5c5a9e428359/molecules-24-02529-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/e5a53158948f/molecules-24-02529-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/eb4750d7356b/molecules-24-02529-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a1e/6680532/5b46aa189546/molecules-24-02529-g008.jpg

相似文献

1
High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.高影响力:别构结合位点在多靶标药物化学中的作用。
Molecules. 2019 Jul 10;24(14):2529. doi: 10.3390/molecules24142529.
2
Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.药物混杂性在 PDB 中的体现:蛋白结合位点相似性是关键。
PLoS One. 2013 Jun 21;8(6):e65894. doi: 10.1371/journal.pone.0065894. Print 2013.
3
Analyzing Promiscuity at the Level of Active Compounds and Targets.从活性化合物和靶点层面分析滥交现象。 不过需要说明的是,这里“promiscuity”在医学语境中可能不是常见含义,结合上下文可能有更准确的理解,仅按字面翻译是这样。
Mol Inform. 2016 Dec;35(11-12):583-587. doi: 10.1002/minf.201600030. Epub 2016 Apr 28.
4
Polypharmacology: in silico methods of ligand design and development.多药理学:配体设计与开发的计算机模拟方法
Future Med Chem. 2016 Apr;8(5):579-602. doi: 10.4155/fmc-2015-0006. Epub 2016 Apr 13.
5
Protein promiscuity: drug resistance and native functions--HIV-1 case.蛋白质的多特异性:耐药性与天然功能——以HIV-1为例
J Biomol Struct Dyn. 2005 Jun;22(6):615-24. doi: 10.1080/07391102.2005.10531228.
6
Quantifying the tendency of therapeutic target proteins to bind promiscuous or selective compounds.量化治疗靶点蛋白与混杂或选择性化合物结合的倾向。
PLoS One. 2015 May 22;10(5):e0126838. doi: 10.1371/journal.pone.0126838. eCollection 2015.
7
Predicting the multi-modal binding propensity of small molecules: towards an understanding of drug promiscuity.预测小分子的多模态结合倾向:迈向对药物混杂性的理解。
Mol Biosyst. 2009 Aug;5(8):844-53. doi: 10.1039/b901356c. Epub 2009 May 28.
8
GES polypharmacology fingerprints: a novel approach for drug repositioning.基因表达系列分析(GES)多药理学指纹图谱:一种药物重新定位的新方法。
J Chem Inf Model. 2014 Mar 24;54(3):720-34. doi: 10.1021/ci4006723. Epub 2014 Feb 17.
9
Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.多药理学重新评分:用于远程结合位点相似性评估的蛋白质-配体相互作用图谱。
Prog Biophys Mol Biol. 2014 Nov-Dec;116(2-3):174-86. doi: 10.1016/j.pbiomolbio.2014.05.006. Epub 2014 Jun 9.
10
Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.Binding MOAD(所有数据库之母)更新:多靶标药物发现工具及其在药物重定位中的应用。
J Mol Biol. 2019 Jun 14;431(13):2423-2433. doi: 10.1016/j.jmb.2019.05.024. Epub 2019 May 22.

引用本文的文献

1
DRLiPS: a novel method for prediction of druggable RNA-small molecule binding pockets using machine learning.DRLiPS:一种使用机器学习预测可成药RNA-小分子结合口袋的新方法。
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf239.
2
Hypothesis-generating proteome perturbation to identify NEU-4438 and acoziborole modes of action in the African Trypanosome.用于生成假设的蛋白质组扰动,以确定非洲锥虫中NEU-4438和氨苯砜硼烷的作用模式。
iScience. 2022 Oct 7;25(11):105302. doi: 10.1016/j.isci.2022.105302. eCollection 2022 Nov 18.
3
Complementary Dual Approach for In Silico Target Identification of Potential Pharmaceutical Compounds in Cystic Fibrosis.

本文引用的文献

1
Small Multitarget Molecules Incorporating the Enone Moiety.包含烯酮部分的小分子多靶标分子。
Molecules. 2019 Jan 7;24(1):199. doi: 10.3390/molecules24010199.
2
Privileged Structures and Polypharmacology within and between Protein Families.蛋白质家族内部及之间的特权结构与多药理学
ACS Med Chem Lett. 2018 Nov 16;9(12):1199-1204. doi: 10.1021/acsmedchemlett.8b00364. eCollection 2018 Dec 13.
3
Serum carbonic anhydrase I and II autoantibodies in patients with chronic lymphocytic leukaemia.慢性淋巴细胞白血病患者血清中的碳酸酐酶I和II自身抗体
互补双途径法在囊性纤维化潜在药物化合物的计算机目标识别中的应用
Int J Mol Sci. 2022 Oct 15;23(20):12351. doi: 10.3390/ijms232012351.
4
The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.药物和生物技术产品的转运体介导的细胞摄取和外排:为什么磷脂双层转运在真实生物膜中可以忽略不计。
Molecules. 2021 Sep 16;26(18):5629. doi: 10.3390/molecules26185629.
5
An up-to-date overview of computational polypharmacology in modern drug discovery.计算药物多靶性在现代药物发现中的最新概述。
Expert Opin Drug Discov. 2020 Sep;15(9):1025-1044. doi: 10.1080/17460441.2020.1767063. Epub 2020 May 26.
Cent Eur J Immunol. 2018;43(3):276-280. doi: 10.5114/ceji.2018.80046. Epub 2018 Oct 30.
4
Binding site matching in rational drug design: algorithms and applications.理性药物设计中的结合位点匹配:算法与应用。
Brief Bioinform. 2019 Nov 27;20(6):2167-2184. doi: 10.1093/bib/bby078.
5
Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.深度学习和机器智能在计算机药物发现中的最新应用:方法、工具和数据库。
Brief Bioinform. 2019 Sep 27;20(5):1878-1912. doi: 10.1093/bib/bby061.
6
Rational application of drug promiscuity in medicinal chemistry.药用化学中药物混杂的合理应用。
Future Med Chem. 2018 Aug 1;10(15):1835-1851. doi: 10.4155/fmc-2018-0018. Epub 2018 Jul 18.
7
Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and Protein-Protein interaction network.通过基于计算消减基因组学和蛋白质-蛋白质相互作用网络的核心蛋白质组学分析,对铜绿假单胞菌的潜在药物靶点进行优先级排序。
Comput Biol Chem. 2018 Jun;74:115-122. doi: 10.1016/j.compbiolchem.2018.02.017. Epub 2018 Mar 8.
8
Comparative assessment of strategies to identify similar ligand-binding pockets in proteins.比较评估鉴定蛋白质中相似配体结合口袋的策略。
BMC Bioinformatics. 2018 Mar 9;19(1):91. doi: 10.1186/s12859-018-2109-2.
9
Target class drug discovery.靶向药物发现。
Nat Chem Biol. 2017 Sep 19;13(10):1053-1056. doi: 10.1038/nchembio.2473.
10
A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds.揭示具有药理活性的化合物的非选择性靶标作用的计算方法。
Angew Chem Int Ed Engl. 2017 Sep 11;56(38):11520-11524. doi: 10.1002/anie.201706376. Epub 2017 Aug 7.